Suppr超能文献

TOE1是一种具有细胞穿透能力的HIV-1复制抑制剂。

TOE1 is an inhibitor of HIV-1 replication with cell-penetrating capability.

作者信息

Sperandio Sabina, Barat Corinne, Cabrita Miguel A, Gargaun Ana, Berezovski Maxim V, Tremblay Michel J, de Belle Ian

机构信息

Ottawa Hospital Research Institute, Program in Cancer Therapeutics, The Ottawa Hospital, Ottawa, ON, Canada K1H 8L6;

Axe des Maladies Infectieuses et Immunitaires, Centre de Recherche du Centre Hospitalier Universitaire (CHU) de Québec-Université Laval, Quebec, QC, Canada G1V 4G2;

出版信息

Proc Natl Acad Sci U S A. 2015 Jun 30;112(26):E3392-401. doi: 10.1073/pnas.1500857112. Epub 2015 Jun 8.

Abstract

Target of Egr1 (TOE1) is a nuclear protein localized primarily in nucleoli and Cajal bodies that was identified as a downstream target of the immediate early gene Egr1. TOE1 displays a functional deadenylation domain and has been shown to participate in spliceosome assembly. We report here that TOE1 can function as an inhibitor of HIV-1 replication and show evidence that supports a direct interaction of TOE1 with the viral specific transactivator response element as part of the inhibitory mechanism. In addition, we show that TOE1 can be secreted by activated CD8(+) T lymphocytes and can be cleaved by the serine protease granzyme B, one of the main components of cytotoxic granules. Both full-length and cleaved TOE1 can spontaneously cross the plasma membrane and penetrate cells in culture, retaining HIV-1 inhibitory activity. Antiviral potency of TOE1 and its cell-penetrating capability have been identified to lie within a 35-amino-acid region containing the nuclear localization sequence.

摘要

Egr1的靶标(TOE1)是一种主要定位于核仁与卡哈尔体的核蛋白,它被鉴定为即刻早期基因Egr1的下游靶标。TOE1具有一个功能性去腺苷酸化结构域,并且已被证明参与剪接体组装。我们在此报告,TOE1可作为HIV-1复制的抑制剂发挥作用,并展示了支持TOE1与病毒特异性反式激活应答元件直接相互作用作为抑制机制一部分的证据。此外,我们表明TOE1可由活化的CD8(+) T淋巴细胞分泌,并且可被细胞毒性颗粒的主要成分之一丝氨酸蛋白酶颗粒酶B切割。全长和切割后的TOE1均可自发穿过质膜并穿透培养中的细胞,保留HIV-1抑制活性。已确定TOE1的抗病毒效力及其细胞穿透能力位于一个包含核定位序列的35个氨基酸区域内。

相似文献

1
TOE1 is an inhibitor of HIV-1 replication with cell-penetrating capability.
Proc Natl Acad Sci U S A. 2015 Jun 30;112(26):E3392-401. doi: 10.1073/pnas.1500857112. Epub 2015 Jun 8.
2
TOE1 interacts with p53 to modulate its transactivation potential.
FEBS Lett. 2009 Jul 7;583(13):2165-70. doi: 10.1016/j.febslet.2009.06.004. Epub 2009 Jun 7.
3
Discovery of another anti-HIV protein in the search for the CD8+ cell anti-HIV Factor.
Proc Natl Acad Sci U S A. 2015 Jun 30;112(26):7888-9. doi: 10.1073/pnas.1509324112. Epub 2015 Jun 17.
5
PARN and TOE1 Constitute a 3' End Maturation Module for Nuclear Non-coding RNAs.
Cell Rep. 2018 Apr 17;23(3):888-898. doi: 10.1016/j.celrep.2018.03.089.
10
Derivation of infectious HIV-1 molecular clones with LTR mutations: sensitivity to the CD8+ cell noncytotoxic anti-HIV response.
Virology. 2008 Mar 30;373(1):30-8. doi: 10.1016/j.virol.2007.11.003. Epub 2007 Dec 20.

引用本文的文献

1
ZFP36 Facilitates Senecavirus A (SVA) replication by inhibiting the production of type I interferon.
Virus Res. 2024 Dec;350:199498. doi: 10.1016/j.virusres.2024.199498. Epub 2024 Nov 18.
2
Viruses and Cajal Bodies: A Critical Cellular Target in Virus Infection?
Viruses. 2023 Nov 25;15(12):2311. doi: 10.3390/v15122311.
3
Cell-Penetrating Antimicrobial Peptides with Anti-Infective Activity against Intracellular Pathogens.
Antibiotics (Basel). 2022 Dec 8;11(12):1772. doi: 10.3390/antibiotics11121772.
5
Zinc Finger Protein ZFP36L1 Inhibits Flavivirus Infection by both 5'-3' XRN1 and 3'-5' RNA-Exosome RNA Decay Pathways.
J Virol. 2022 Jan 12;96(1):e0166521. doi: 10.1128/JVI.01665-21. Epub 2021 Oct 13.
6
The CD8 T Cell Noncytotoxic Antiviral Responses.
Microbiol Mol Biol Rev. 2021 May 12;85(2). doi: 10.1128/MMBR.00155-20. Print 2021 May 19.
7
Canonical Wnts Mediate CD8 T Cell Noncytolytic Anti-HIV-1 Activity and Correlate with HIV-1 Clinical Status.
J Immunol. 2020 Oct 15;205(8):2046-2055. doi: 10.4049/jimmunol.1801379. Epub 2020 Sep 4.
10
The Tat inhibitor didehydro-cortistatin A suppresses SIV replication and reactivation.
FASEB J. 2019 Jul;33(7):8280-8293. doi: 10.1096/fj.201801165R. Epub 2019 Apr 25.

本文引用的文献

1
A survey on "Trojan Horse" peptides: opportunities, issues and controlled entry to "Troy".
J Control Release. 2014 Nov 28;194:53-70. doi: 10.1016/j.jconrel.2014.08.014. Epub 2014 Aug 23.
2
Whole-genome screening identifies proteins localized to distinct nuclear bodies.
J Cell Biol. 2013 Oct 14;203(1):149-64. doi: 10.1083/jcb.201303145.
3
Unravelling the mechanisms of durable control of HIV-1.
Nat Rev Immunol. 2013 Jul;13(7):487-98. doi: 10.1038/nri3478.
4
Granzyme B-dependent proteolysis acts as a switch to enhance the proinflammatory activity of IL-1α.
Mol Cell. 2011 Oct 21;44(2):265-78. doi: 10.1016/j.molcel.2011.07.037.
6
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
Science. 2010 Dec 10;330(6010):1551-7. doi: 10.1126/science.1195271. Epub 2010 Nov 4.
7
Non-cytotoxic antiviral activities of granzymes in the context of the immune antiviral state.
Immunol Rev. 2010 May;235(1):128-46. doi: 10.1111/j.0105-2896.2010.00909.x.
8
Cytotoxic and non-cytotoxic roles of the CTL/NK protease granzyme B.
Immunol Rev. 2010 May;235(1):105-16. doi: 10.1111/j.0105-2896.2010.00908.x.
9
Functions of Tat: the versatile protein of human immunodeficiency virus type 1.
J Gen Virol. 2010 Jan;91(Pt 1):1-12. doi: 10.1099/vir.0.016303-0. Epub 2009 Oct 7.
10
TOE1 interacts with p53 to modulate its transactivation potential.
FEBS Lett. 2009 Jul 7;583(13):2165-70. doi: 10.1016/j.febslet.2009.06.004. Epub 2009 Jun 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验